The Food and Drug Administration (FDA) told the maker of Purell to discontinue marketing campaigns that includes claims for avoiding flu and ebola, according to an article on The New York Times website.
The campaigns also claim the product can prevent spread of MRSA and norovirus.
The FDA told Gojo Industries that its claims that Purell could reduce the potential for infection or prevent illnesses violated the Federal Food, Drug and Cosmetic Act.
The agency said it was reclassifying Purell as an unapproved drug, rather than an over-the-counter product.
Two Steps to Controlling the Hot Zone
RiverSpring Living Breaks Ground on River's Edge Senior Living Community
Encompass Health Reveals Plans to Build Inpatient Rehabilitation Hospital in Post Falls, Idaho
Creating Compassionate Spaces in Healthcare
Study Shows Connection Between Odor and Patient Experience